Health & Biotech
At Argent BioPharma, our mission is to revolutionize healthcare through pioneering innovation.
We go beyond traditional disease management by exploring the intricacies of the immune system and harnessing cutting-edge technologies in our research and development endeavors.
Through our commitment to advancing medical science, we aim to reshape the landscape of global healthcare by addressing unmet needs and offering hope to underserved populations worldwide.
Our vision encompasses becoming a leading biopharmaceutical company renowned for groundbreaking medical treatments. By embracing NanoPolyPharmacology, we strive to introduce impactful solutions that elevate standards within the life sciences industry. Our dedication extends to ensuring accessibility to innovative therapies for communities overlooked by conventional medical approaches, thereby bridging healthcare disparities on a global scale.
As we progress on this ambitious path, we invite you to follow our journey and be a part of a transformative shift in healthcare. At Argent BioPharma, we’re not just changing treatments; we’re changing lives.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Stockhead TV
VIDEO: 90 Seconds With… Roby Zomer, MGC Pharmaceuticals
Health & Biotech
MGC Pharma prepping follow-up studies after brain cancer results
News
Weed Week: Oz gets serious with medical marijuana, new clinics rolling out soon
Health & Biotech
Could cannabinoids be the answer to aggressive brain cancer?
Health & Biotech
Cash-flow surge: MGC Pharma boosts outlook as revenue accelerates in the June quarter
News
Weed Week: Illinois legalises recreational pot use… and now, the US Feds can’t interfere
Health & Biotech
MGC takes a Euro trip and hits Germany with a brand new dist deal
Health & Biotech
Health: Althea scores first UK customer, eyes off local processing facility
Health & Biotech
Pot stock MGC Pharma is racing into Brazil with new distribution deal
Health & Biotech
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
Health & Biotech
Medicinal cannabis distributors are loving what MGC is selling
Health & Biotech
MGC Pharma pulls in over half a million in Q2 revenue
News
Weed Week: Which of you were forced to sell your beloved pot stocks last week?
News
Weed Week: Will Australia fear to tread where NZ steps with cannabis legalisation?
Health & Biotech
MGC births first cannabis products into the UK
Health & Biotech
Epilepsy and dementia sufferers across the globe to benefit from new MGC Pharma agreements
Health & Biotech